An alternative explanation for the limited ICB responses in patients with HPV+ HNSCC might be the presence of additional, unknown immunoregulatory mechanisms preventing the proliferation and differentiation of HPV-specific stem-like CD8+ T cells or the execution of sufficient effector functions of their cytotoxic progeny upon ICB. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.